# Nimodipine

## Nimotop inj 10mg/ 50mL

| 藥物代碼 | INIM |
| :--- | :--- |
| 適應症 | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage. |
| 副作用 | Hypotension, GI disturbances. |
| 禁忌 | Must not be administered to patients with severely impaired liver function |
| 藥物保存方式 | N/A |
| 用法用量 | Prophylactic use: Initially administer IV infusion at 1 mg/hr for 2 hr, then increase to 2 mg/hr for 10-14 days, followed by 2 tab 4 hrly, 12 tab/day for 7 days. Patient &lt;70 kg or with unstable BP Should be started with 0.5 mg/hr. Therapeutic use: If ischaemic neurological disturbances caused by vasospasm are already present, treatment should be started continued for 5-14 days. Thereafter oral administration as above-mentioned oral regimen. |
| 肝功能異常 | 需 調 整 劑 量  嚴重肝功能障礙病患\(especially liver cirrhosis\),建議30 mg ORALLY every 4 hours 或考慮停止治療 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | CVC, IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【L/R】 可選  【N/S】 可選 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 起始速率:15 mcg/kg/hr 輸注速率 &lt; 2mg/hr \(本藥應與溶液以一比四比例經由三向活塞給予\) |
| 注意事項 | 1. Nimotop輸注液需使用輸注幫浦以連續靜脈輸注經由中央靜脈導管\(central catheter\) 注入體內。 2. 藥品勿直接加入點滴,而以three-way stoplock給予 3. 由於藥品的有效成分會被聚氯乙烯\(PVC\)吸附，因此只能使用聚乙烯\(PE\)的輸注管。 |

## Nimotop F.C 30mg

| 藥物代碼 | ONIM |
| :--- | :--- |
| 適應症 | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage. |
| 副作用 | Hypotension, GI disturbances. |
| 禁忌 | patients with severely impaired liver function \(eg, cirrhosis of the liver\). In view of its indication area, Nimotop tablet is not used during pregnancy or lactation. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Initially administer IV infusion at 1 mg/hr for 2 hr, then increase to 2 mg/hr for 7-14 days,followed by 2 tab 4 hrly, 12 tab/day for 7 days. Patient &lt; 70kg or with unstable BP Start with 0.5 mg/hr or less if necessary, for 11-14 days then followed by 2 tab 4 hrly,12 tab/day for 7 days. |
| 肝功能異常 | 需 調 整 劑 量  嚴重肝功能障礙病患\(especially liver cirrhosis\),建議30 mg ORALLY every 4 hours 或考慮停止治療 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

